Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Polymerase Chain Reaction Versus Blood Culture to Detect Candida Species in High-Risk Patients with Suspected Invasive Candidiasis: The MICAFEM Study.

Nieto M, Robles JC, Causse M, Gutiérrez L, Cruz Perez M, Ferrer R, Xercavins M, Herrero E, Sirvent E, Fernández C, Anguita P, Merino P; MICAFEM Study Group, GEIPC (SEIMC) and GTEIS (SEMICYUC).

Infect Dis Ther. 2019 May 24. doi: 10.1007/s40121-019-0248-z. [Epub ahead of print]

PMID:
31127539
2.

Assessment of Quality Indicators for Appropriate Antibiotic Use.

Arcenillas P, Boix-Palop L, Gómez L, Xercavins M, March P, Martinez L, Riera M, Madridejos R, Badia C, Nicolás J, Calbo E.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00875-18. doi: 10.1128/AAC.00875-18. Print 2018 Dec.

3.

Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria.

Cepas V, López Y, Muñoz E, Rolo D, Ardanuy C, Martí S, Xercavins M, Horcajada JP, Bosch J, Soto SM.

Microb Drug Resist. 2019 Jan/Feb;25(1):72-79. doi: 10.1089/mdr.2018.0027. Epub 2018 Aug 24.

PMID:
30142035
4.

Diagnosing catheter-associated urinary tract infection: Still a matter of concern.

Jordano Q, Molina M, Acosta E, Xercavins M, de la Sierra A.

Eur J Intern Med. 2018 Jun;52:e30-e31. doi: 10.1016/j.ejim.2018.03.001. Epub 2018 Mar 8. No abstract available.

PMID:
29526652
5.

Serotype, virulence profile, antimicrobial resistance and macrolide-resistance determinants in Streptococcus agalactiae isolates in pregnant women and neonates in Catalonia, Spain.

López Y, Parra E, Cepas V, Sanfeliú I, Juncosa T, Andreu A, Xercavins M, Pérez J, Sanz S, Vergara A, Bosch J, Soto SM.

Enferm Infecc Microbiol Clin. 2018 Oct;36(8):472-477. doi: 10.1016/j.eimc.2017.08.006. Epub 2017 Oct 10. English, Spanish.

PMID:
29029763
6.

Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.

Boix-Palop L, Xercavins M, Badía C, Obradors M, Riera M, Freixas N, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

Int J Antimicrob Agents. 2017 Aug;50(2):197-202. doi: 10.1016/j.ijantimicag.2017.03.009. Epub 2017 May 24.

PMID:
28552471
7.

Bacillus species pseudo-outbreak: construction works and collateral damage.

Boix-Palop L, Nicolás C, Xercavins M, Riera M, Prim N, Freixas N, Pérez J, Calbo E.

J Hosp Infect. 2017 Jan;95(1):118-122. doi: 10.1016/j.jhin.2016.10.013. Epub 2016 Oct 24.

PMID:
27856013
8.

Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

Pascual V, Alonso N, Simó M, Ortiz G, Garcia MC, Xercavins M, Rivera A, Morera MA, Miró E, Espejo E, Navarro F, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1997-2003. Epub 2016 Aug 22.

PMID:
27549108
9.

CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.

Merino I, Shaw E, Horcajada JP, Cercenado E, Mirelis B, Pallarés MA, Gómez J, Xercavins M, Martínez-Martínez L, De Cueto M, Cantón R, Ruiz-Garbajosa P; ITUBRAS-GEIH-SEIMC Group.

J Antimicrob Chemother. 2016 Aug;71(8):2125-30. doi: 10.1093/jac/dkw133. Epub 2016 May 12.

PMID:
27494832
10.

Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.

Alonso N, Miró E, Pascual V, Rivera A, Simó M, Garcia MC, Xercavins M, Morera MA, Espejo E, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E, Navarro F, Mirelis B, Coll P.

Int J Antimicrob Agents. 2016 Jan;47(1):62-8. doi: 10.1016/j.ijantimicag.2015.10.007. Epub 2015 Nov 2.

PMID:
26607336
11.

Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed.

Sangil A, Xercavins M, Rodríguez-Carballeira M, Andrés M, Riera M, Espejo E, Pérez J, Garau J, Calbo E.

J Infect. 2015 Oct;71(4):422-7. doi: 10.1016/j.jinf.2015.07.004. Epub 2015 Jul 18.

PMID:
26192199
12.

Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.

Pascual V, Ortiz G, Simó M, Alonso N, Garcia MC, Xercavins M, Rivera A, Morera MA, Miró E, Espejo E, Navarro F, Gurguí M, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

J Antimicrob Chemother. 2015 Mar;70(3):899-904. doi: 10.1093/jac/dku468. Epub 2014 Dec 2.

PMID:
25468902
13.

Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control.

Calbo E, Freixas N, Xercavins M, Riera M, Nicolás C, Monistrol O, Solé Mdel M, Sala MR, Vila J, Garau J.

Clin Infect Dis. 2011 Mar 15;52(6):743-9. doi: 10.1093/cid/ciq238.

PMID:
21367727
14.

Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected.

Calbo E, Valdés E, Ochoa de Echagüen A, Fleites A, Molinos L, Xercavins M, Freixas N, Rodríguez-Carballeira M, Garau J.

Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):971-6. doi: 10.1007/s10096-009-0737-1. Epub 2009 Apr 10.

PMID:
19360444
15.

Bloodstream infections in adults: importance of healthcare-associated infections.

Vallés J, Calbo E, Anoro E, Fontanals D, Xercavins M, Espejo E, Serrate G, Freixas N, Morera MA, Font B, Bella F, Segura F, Garau J.

J Infect. 2008 Jan;56(1):27-34. Epub 2007 Nov 19.

PMID:
18022242
16.

Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine.

Calbo E, Díaz A, Cañadell E, Fábrega J, Uriz S, Xercavins M, Morera MA, Cuchi E, Rodríguez-Carballeira M, Garau J; Spanish Pneumococcal Infection Study Network.

Clin Microbiol Infect. 2006 Sep;12(9):867-72.

17.

Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status.

Johnson JR, Kuskowski MA, Menard M, Gajewski A, Xercavins M, Garau J.

J Infect Dis. 2006 Jul 1;194(1):71-8. Epub 2006 May 31.

PMID:
16741884
18.

Candidemia in neonatal intensive care units: Barcelona, Spain.

Rodriguez D, Almirante B, Park BJ, Cuenca-Estrella M, Planes AM, Sanchez F, Gene A, Xercavins M, Fontanals D, Rodriguez-Tudela JL, Warnock DW, Pahissa A; Barcelona Candidemia Project Study Group.

Pediatr Infect Dis J. 2006 Mar;25(3):224-9.

PMID:
16511384
19.

Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.

J Antimicrob Chemother. 2006 Apr;57(4):780-3. Epub 2006 Feb 21.

PMID:
16492721
20.

Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.

Ochoa de Echagüen A, Arnedo M, Xercavins M, Martinez E, Rosón B, Ribera E, Domingo P, González A, Riera M, Llibre JM, Gatell JM, Dalmau D; Nevirapine, Efavirenz and Abacavir (NEFA) Resistance Substudy Team.

AIDS. 2005 Sep 2;19(13):1385-91.

PMID:
16103769
21.

Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.

Gomez L, Garau J, Estrada C, Marquez M, Dalmau D, Xercavins M, Martí JM, Estany C.

Cancer. 2003 Jan 15;97(2):419-24.

22.

Hospital-acquired pneumococcal bacteremia.

Canet JJ, Juan N, Xercavins M, Freixas N, Garau J.

Clin Infect Dis. 2002 Sep 15;35(6):697-702. Epub 2002 Aug 26.

PMID:
12203167
23.

Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.

Lonks JR, Garau J, Gomez L, Xercavins M, Ochoa de Echagüen A, Gareen IF, Reiss PT, Medeiros AA.

Clin Infect Dis. 2002 Sep 1;35(5):556-64. Epub 2002 Aug 9.

PMID:
12173129
24.

Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

Garau J, Xercavins M, Rodríguez-Carballeira M, Gómez-Vera JR, Coll I, Vidal D, Llovet T, Ruíz-Bremón A.

Antimicrob Agents Chemother. 1999 Nov;43(11):2736-41.

25.

Thoracic infection caused by Streptococcus milleri.

Porta G, Rodríguez-Carballeira M, Gómez L, Salavert M, Freixas N, Xercavins M, Garau J.

Eur Respir J. 1998 Aug;12(2):357-62.

26.

Urovirulence determinants in Escherichia coli strains causing prostatitis.

Andreu A, Stapleton AE, Fennell C, Lockman HA, Xercavins M, Fernandez F, Stamm WE.

J Infect Dis. 1997 Aug;176(2):464-9. Erratum in: J Infect Dis 1997 Nov;176(5):1416.

PMID:
9237713
27.

Epidemiology of an unusually prolonged outbreak of typhoid fever in Terrassa, Spain.

Xercavins M, Llovet T, Navarro F, Morera MA, Moré J, Bella F, Freixas N, Simó M, Echeita A, Coll P, Garau J, Prats G.

Clin Infect Dis. 1997 Mar;24(3):506-10.

PMID:
9114207
28.

Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.

Salavert M, Gómez L, Rodriguez-Carballeira M, Xercavins M, Freixas N, Garau J.

Eur J Clin Microbiol Infect Dis. 1996 May;15(5):365-71.

PMID:
8793393
29.

[Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].

López-Yeste M, Xercavins M, Lite J, Cuchí E, Garau J.

Enferm Infecc Microbiol Clin. 1996 Apr;14(4):211-4. Spanish.

PMID:
9044634
30.

Urinary tract infection by Aeromonas hydrophila in a neonate.

Bartolomé RM, Andreu A, Xercavins M, Elcuaz R, Salcedo S.

Infection. 1989 May-Jun;17(3):172-3. No abstract available.

PMID:
2737762
31.

[Pleural empyema caused by Legionella pneumophila].

Ribera E, Ferrer A, Gelabert R, Xercavins M, Martínez-Vázquez JM.

Med Clin (Barc). 1989 Apr 29;92(16):605-7. Spanish.

PMID:
2747322
32.

[Type 1 fimbriae, P fimbriae and X adhesins in Escherichia strains causing pyelonephritis, cystitis and recurrent urinary infections].

Andreu A, Xercavins M, Fernández F.

Med Clin (Barc). 1989 Mar 25;92(11):409-12. Spanish.

PMID:
2566727
33.

[Isolation of Vibrio alginolyticus from a patient with chronic otitis].

Xercavins M, Gasser I, Pumarola F, Fernández F.

Enferm Infecc Microbiol Clin. 1989 Feb;7(2):115-6. Spanish. No abstract available.

PMID:
2490665

Supplemental Content

Loading ...
Support Center